- Home
- SNDX vs CIM Comparison
SNDX vs CIM Comparison
Compare SNDX & CIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDX
- CIM
- Stock Information
- Founded
- SNDX 2005
- CIM 2007
- Country
- SNDX United States
- CIM United States
- Employees
- SNDX N/A
- CIM N/A
- Industry
- SNDX Biotechnology: Pharmaceutical Preparations
- CIM Real Estate Investment Trusts
- Sector
- SNDX Health Care
- CIM Real Estate
- Exchange
- SNDX Nasdaq
- CIM Nasdaq
- Market Cap
- SNDX 1.4B
- CIM 1.2B
- IPO Year
- SNDX 2016
- CIM 2007
- Fundamental
- Price
- SNDX $13.63
- CIM $14.95
- Analyst Decision
- SNDX Strong Buy
- CIM Hold
- Analyst Count
- SNDX 11
- CIM 1
- Target Price
- SNDX $37.64
- CIM $16.00
- AVG Volume (30 Days)
- SNDX 1.9M
- CIM 430.5K
- Earning Date
- SNDX 11-05-2024
- CIM 02-12-2025
- Dividend Yield
- SNDX N/A
- CIM 9.97%
- EPS Growth
- SNDX N/A
- CIM 117.60
- EPS
- SNDX N/A
- CIM 3.36
- Revenue
- SNDX $16,000,000.00
- CIM $442,341,000.00
- Revenue This Year
- SNDX N/A
- CIM N/A
- Revenue Next Year
- SNDX N/A
- CIM $11.33
- P/E Ratio
- SNDX N/A
- CIM $4.41
- Revenue Growth
- SNDX N/A
- CIM 44.27
- 52 Week Low
- SNDX $13.26
- CIM $11.29
- 52 Week High
- SNDX $25.34
- CIM $16.89
- Technical
- Relative Strength Index (RSI)
- SNDX 30.64
- CIM 48.05
- Support Level
- SNDX $13.36
- CIM $14.79
- Resistance Level
- SNDX $14.18
- CIM $15.28
- Average True Range (ATR)
- SNDX 0.81
- CIM 0.25
- MACD
- SNDX -0.18
- CIM 0.03
- Stochastic Oscillator
- SNDX 11.32
- CIM 39.05
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.
About CIM Chimera Investment Corporation
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.